A networking event and exhibition for people who work in bioscience, pharma and drug discovery, the LATi 2015 Chemistry Showcase will bring together the who's who from bioscience, biotech and pharma to talk about how to engage with Big Pharma.
Gerry Thomas of Sygnature Discovery is to give the opening address, providing insights and insider advice on how to engage with big pharma companies.
Gerry has experience of leading programs from hit finding to Phase II clinical studies and has previously worked at OSI Prosidion, Shire, BASF(Knoll) and Boots Pharmaceuticals.
David Lathbury PhD, the Director of Astute Chemical Development Consultancy, the former Director of Process Chemistry at Astra Zeneca, and Vice President of Chemical Development at AMRI is to provide the closing address.
Drawing from his experience of working for some of the largest pharmas and running his own consultancy, David Lathbury will be addressing the question of whether SMEs should engage with Big Pharma.
David will be talking about the differences in approaches, time lines and costs. He will also cover the ease of forming long term productive relationships that can lead to long term business, and the risks and rewards for SMEs of forming these relationships.
5-minute soapbox speakers include Faz Chowdhury of Nemaura Pharma, Alan Harris of Alacrity Pharma Associates, Tony Mete of Medsyndesign, Gerry Steele of Pharmacryst, Jonathan Moss of BAST, and Steve Brough of Key Organics.
Over 15 companies will be exhibiting at the event, including Medilink East Midlands, UKTI, NTU working with you, Adamson Jones, Lacerta Technology, Datalink Electronics, Nemaura Pharma, Medsyndesign, Alacrity Pharma, Pharmacryst, BAST and 3M Medical.
Refreshments will be served.
Cost of attending the event is £30 per person.
Gerry Thomas of Sygnature Discovery is to give the opening address, providing insights and insider advice on how to engage with big pharma companies.
Gerry has experience of leading programs from hit finding to Phase II clinical studies and has previously worked at OSI Prosidion, Shire, BASF(Knoll) and Boots Pharmaceuticals.
David Lathbury PhD, the Director of Astute Chemical Development Consultancy, the former Director of Process Chemistry at Astra Zeneca, and Vice President of Chemical Development at AMRI is to provide the closing address.
Drawing from his experience of working for some of the largest pharmas and running his own consultancy, David Lathbury will be addressing the question of whether SMEs should engage with Big Pharma.
David will be talking about the differences in approaches, time lines and costs. He will also cover the ease of forming long term productive relationships that can lead to long term business, and the risks and rewards for SMEs of forming these relationships.
5-minute soapbox speakers include Faz Chowdhury of Nemaura Pharma, Alan Harris of Alacrity Pharma Associates, Tony Mete of Medsyndesign, Gerry Steele of Pharmacryst, Jonathan Moss of BAST, and Steve Brough of Key Organics.
Over 15 companies will be exhibiting at the event, including Medilink East Midlands, UKTI, NTU working with you, Adamson Jones, Lacerta Technology, Datalink Electronics, Nemaura Pharma, Medsyndesign, Alacrity Pharma, Pharmacryst, BAST and 3M Medical.
Refreshments will be served.
Cost of attending the event is £30 per person.
